Skip to content
Clinical Trials – home

Diagnostic-consultative center “Aleksandrovska” EOOD

Verifiedinfo

Bulgaria Triaditsa, Ulitsa Sveti Georgi Sofiyski 1, 1431 Sofia, Bulgaria

  • 71 trials recruiting
  • Asthma · Dermatitis atopic · Systemic lupus erythematosus
  • Adults and children

About Specializations

Diagnostic-consultative center “Aleksandrovska” EOOD in Sofia, Bulgaria specialises in clinical trials of conditions such as Asthma, Dermatitis atopic, Systemic lupus erythematosus, Obesity, and other specialisations. This site conducts important research.

Main research areas of the site

Digestive System Diseases

Clinical research at Diagnostic-consultative center “Aleksandrovska” EOOD includes studies in Digestive System Diseases, with a strong focus on Crohn's disease. These trials are designed to evaluate new treatment options and better understand how therapies may improve disease control and intestinal health.

  • Testing new therapies for Crohn's disease
  • Assessing treatment effectiveness in Digestive System Diseases
  • Studying responses to therapy in patients with inflammatory bowel conditions

The site is contributing to research that aims to improve care for people living with chronic digestive inflammation and to support more effective long-term management strategies.

Immune System Diseases

Another key area of work is Immune System Diseases, especially chronic spontaneous urticaria. The trials here are focused on evaluating whether new treatments can reduce symptoms such as hives and itch while also examining safety and overall tolerability.

  • Investigating therapies for chronic spontaneous urticaria
  • Measuring symptom improvement in immune-related skin conditions
  • Checking safety and tolerability of emerging treatment options

These studies help advance care for patients whose immune-related symptoms can be persistent and difficult to manage.

Skin and Connective Tissue Diseases

Research in Skin and Connective Tissue Diseases at the Sofia site overlaps with immune-mediated skin disorders, particularly chronic spontaneous urticaria. The clinical trials are aimed at improving diagnostic understanding and testing whether new therapies can provide better relief from visible and uncomfortable skin symptoms.

  • Evaluating treatments for hives without a known cause
  • Exploring symptom relief in skin-related immune disorders
  • Supporting better management of chronic skin conditions

With multiple investigators involved, the center is helping expand research options for patients affected by ongoing skin and connective tissue disease symptoms.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Triaditsa, Ulitsa Sveti Georgi Sofiyski 11431 SofiaBulgaria
Recruiting now
71 trials
Conditions studied
100
Partner status
Verified

More sites in SofiaBulgaria

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

205 clinical trials

Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Lebrikizumab
  • Sponsor:Almirall S.A.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Barzolvolimab
  • Sponsor:Celldex Therapeutics Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Loratadine
  • Sponsor:Pfizer Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Empasiprubart
  • Sponsor:Argenx
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:HUPERZINE A
  • Sponsor:Supernus Pharmaceuticals Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Povorcitinib
  • Sponsor:Incyte Corp.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.